<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01996397</url>
  </required_header>
  <id_info>
    <org_study_id>2013/140</org_study_id>
    <nct_id>NCT01996397</nct_id>
  </id_info>
  <brief_title>Acute Feedback on Left ventrIcular Lead Implantation Location for Cardiac Resynchronization Therapy</brief_title>
  <acronym>CCI impact</acronym>
  <official_title>Acute Feedback on Left ventrIcular Lead Implantation Location for Cardiac Resynchronization Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic Bakken Research Center</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Exploratory, prospective, interventional, non-randomized single-center research study to
      compare metrics derived from 2 or 3-D reconstructions of lead movement, bioimpedance and VCG
      to augmentation of left ventricular contractility (LV dP/dt max) at different pacing
      configurations in patients undergoing a CRT-implant. Pacing sites and contractility data will
      be compared to pre operative cardiac ultrasound and MRI metrics.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>dP\dt max response to different ventricular lead pacing sites</measure>
    <time_frame>6 months</time_frame>
    <description>To compare metrics derived from 2 or 3-D reconstructions of lead movement to augmentation of left ventricular contractility (LV dP/dt max) at different pacing configurations in patients undergoing a CRT-implant Main objective is to identify the optimal LV pacing site within each patient where the force of contraction during BiV pacing is maximized and to assess the feasibility of a non-invasive sensor to identify this optimal site.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lead movements and electrical measures</measure>
    <time_frame>6 months</time_frame>
    <description>Compare metrics derived from 2/3-D reconstructions of lead movement to electrical measures (e.g. Q-LV-timing or VCG) at different pacing configurations in patients undergoing a CRT-implant.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metrics derived from 2/3-D reconstructions of lead movement and Force-Interval-Relation</measure>
    <time_frame>6 months</time_frame>
    <description>To compare metrics derived from 2/3-D reconstructions of lead movement to Force-Interval-Relation at different pacing configurations in patients undergoing a CRT-implant.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metrics derived from 2/3-D reconstructions of lead movement and CardioGuide Motion Map</measure>
    <time_frame>6 months</time_frame>
    <description>To compare metrics derived from 2/3-D reconstructions of lead movement to CardioGuide Motion Map at different pacing configurations in patients undergoing a CRT-implant.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">34</enrollment>
  <condition>Heart Failure</condition>
  <condition>Resynchronization Therapy</condition>
  <condition>Assessment of Acute CRT Response</condition>
  <arm_group>
    <arm_group_label>CRT implantation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Standard CRT indication. Assessment of acute response to CRT.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cardiac resynchronization therapy device implantation</intervention_name>
    <arm_group_label>CRT implantation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject is indicated for CRT or CRT-D device according to current applicable ESC/AHA
             guidelines

          -  Subject is in stable sinus rhythm at the time of implant (no atrial arrhythmias
             lasting &gt; 30 seconds during the last 2 weeks prior to inclusion). No documented
             AF-episodes allowed during the last 2 weeks prior to inclusion.

          -  Subject receives optimal heart failure oral medical therapy (ACE inhibitor and/or ARB
             and Beta Blockers), and is on a stable medication scheme for at least 2 months prior
             to enrollment.

          -  Subject (or the legal guardian) is willing to sign informed consent form

        Exclusion Criteria:

          -  Permanent atrial fibrillation/ flutter or tachycardia

          -  RBBB

          -  Recent myocardial infarction (MI), within 40 days prior to enrollment. Subject
             underwent coronary artery bypass graft (CABG) or valve surgery, within 90 days prior
             to enrollment

          -  Post heart transplantation, or is actively listed on the transplantation list, or has
             reasonable probability (per investigator's discretion) of undergoing transplantation
             in the next year

          -  Implanted with a left ventricular assist device (LVAD), or has reasonable probability
             (per investigator's discretion) of receiving a LVAD in the next year

          -  On chronic renal dialysis, or with severe renal disease (defined as estimated
             Glomerular Filtration Rate (equation provided by Modification of Diet in Renal Disease
             study): (eGFR) &lt; 30 mL/min/1.73m2)

          -  On continuous or uninterrupted infusion (inotropic) therapy for heart failure (≥ 2
             stable infusions a week)

          -  Severe aortic stenosis (with a valve area of &lt;1.0 cm2 or significant valve disease
             expected to be operated on within study period)

          -  Complex and uncorrected congenital heart disease

          -  Mechanical heart valve

          -  Breastfeeding women, or women of child bearing potential and who are not on a reliable
             form of birth control

          -  Enrolled in one or more concurrent studies that would confound the results of this
             study

          -  Already implanted with pacemaker (CRT, CRT-D, ICD) and needs replacement
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Oslo University Hospital, Rikshospitalet</name>
      <address>
        <city>Oslo</city>
        <zip>0424</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <link>
    <url>http://www.heart-sfi.no/</url>
    <description>Center for Cardiological Innovation</description>
  </link>
  <link>
    <url>http://www.oslo-universitetssykehus.no</url>
    <description>Oslo University Hospital</description>
  </link>
  <reference>
    <citation>Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM; Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004 May 20;350(21):2140-50.</citation>
    <PMID>15152059</PMID>
  </reference>
  <reference>
    <citation>Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L; Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005 Apr 14;352(15):1539-49. Epub 2005 Mar 7.</citation>
    <PMID>15753115</PMID>
  </reference>
  <reference>
    <citation>Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Trupp RJ, Underwood J, Pickering F, Truex C, McAtee P, Messenger J; MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002 Jun 13;346(24):1845-53.</citation>
    <PMID>12063368</PMID>
  </reference>
  <reference>
    <citation>Fornwalt BK, Sprague WW, BeDell P, Suever JD, Gerritse B, Merlino JD, Fyfe DA, León AR, Oshinski JN. Agreement is poor among current criteria used to define response to cardiac resynchronization therapy. Circulation. 2010 May 11;121(18):1985-91. doi: 10.1161/CIRCULATIONAHA.109.910778. Epub 2010 Apr 26.</citation>
    <PMID>20421518</PMID>
  </reference>
  <reference>
    <citation>Butter C, Auricchio A, Stellbrink C, Fleck E, Ding J, Yu Y, Huvelle E, Spinelli J; Pacing Therapy for Chronic Heart Failure II Study Group. Effect of resynchronization therapy stimulation site on the systolic function of heart failure patients. Circulation. 2001 Dec 18;104(25):3026-9.</citation>
    <PMID>11748094</PMID>
  </reference>
  <reference>
    <citation>Rossillo A, Verma A, Saad EB, Corrado A, Gasparini G, Marrouche NF, Golshayan AR, McCurdy R, Bhargava M, Khaykin Y, Burkhardt JD, Martin DO, Wilkoff BL, Saliba WI, Schweikert RA, Raviele A, Natale A. Impact of coronary sinus lead position on biventricular pacing: mortality and echocardiographic evaluation during long-term follow-up. J Cardiovasc Electrophysiol. 2004 Oct;15(10):1120-5.</citation>
    <PMID>15485432</PMID>
  </reference>
  <reference>
    <citation>Merchant FM, Heist EK, McCarty D, Kumar P, Das S, Blendea D, Ellinor PT, Mela T, Picard MH, Ruskin JN, Singh JP. Impact of segmental left ventricle lead position on cardiac resynchronization therapy outcomes. Heart Rhythm. 2010 May;7(5):639-44. doi: 10.1016/j.hrthm.2010.01.035. Epub 2010 Feb 1.</citation>
    <PMID>20298819</PMID>
  </reference>
  <reference>
    <citation>Mullens W, Verga T, Grimm RA, Starling RC, Wilkoff BL, Tang WH. Persistent hemodynamic benefits of cardiac resynchronization therapy with disease progression in advanced heart failure. J Am Coll Cardiol. 2009 Feb 17;53(7):600-7. doi: 10.1016/j.jacc.2008.08.079.</citation>
    <PMID>19215835</PMID>
  </reference>
  <reference>
    <citation>Blendea D, Singh JP. Lead positioning strategies to enhance response to cardiac resynchronization therapy. Heart Fail Rev. 2011 May;16(3):291-303. doi: 10.1007/s10741-010-9212-4. Review.</citation>
    <PMID>21184174</PMID>
  </reference>
  <reference>
    <citation>Duckett SG, Ginks M, Shetty AK, Bostock J, Gill JS, Hamid S, Kapetanakis S, Cunliffe E, Razavi R, Carr-White G, Rinaldi CA. Invasive acute hemodynamic response to guide left ventricular lead implantation predicts chronic remodeling in patients undergoing cardiac resynchronization therapy. J Am Coll Cardiol. 2011 Sep 6;58(11):1128-36. doi: 10.1016/j.jacc.2011.04.042.</citation>
    <PMID>21884950</PMID>
  </reference>
  <reference>
    <citation>Bogaard MD, Houthuizen P, Bracke FA, Doevendans PA, Prinzen FW, Meine M, van Gelder BM. Baseline left ventricular dP/dtmax rather than the acute improvement in dP/dtmax predicts clinical outcome in patients with cardiac resynchronization therapy. Eur J Heart Fail. 2011 Oct;13(10):1126-32. doi: 10.1093/eurjhf/hfr094. Epub 2011 Jul 26.</citation>
    <PMID>21791536</PMID>
  </reference>
  <reference>
    <citation>Butter C, Stellbrink C, Belalcazar A, Villalta D, Schlegl M, Sinha A, Cuesta F, Reister C. Cardiac resynchronization therapy optimization by finger plethysmography. Heart Rhythm. 2004 Nov;1(5):568-75.</citation>
    <PMID>15851221</PMID>
  </reference>
  <reference>
    <citation>Whinnett ZI, Davies JE, Willson K, Chow AW, Foale RA, Davies DW, Hughes AD, Francis DP, Mayet J. Determination of optimal atrioventricular delay for cardiac resynchronization therapy using acute non-invasive blood pressure. Europace. 2006 May;8(5):358-66.</citation>
    <PMID>16635996</PMID>
  </reference>
  <reference>
    <citation>Whinnett ZI, Davies JE, Willson K, Manisty CH, Chow AW, Foale RA, Davies DW, Hughes AD, Mayet J, Francis DP. Haemodynamic effects of changes in atrioventricular and interventricular delay in cardiac resynchronisation therapy show a consistent pattern: analysis of shape, magnitude and relative importance of atrioventricular and interventricular delay. Heart. 2006 Nov;92(11):1628-34. Epub 2006 May 18.</citation>
    <PMID>16709698</PMID>
  </reference>
  <reference>
    <citation>Bocchiardo M, Meyer zu Vilsendorf D, Militello C, Lippert M, Czygan G, Schauerte P, Gaita F, Stellbrink C. Resynchronization therapy optimization by intracardiac impedance. Europace. 2010 Nov;12(11):1589-95. doi: 10.1093/europace/euq273. Epub 2010 Jul 28.</citation>
    <PMID>20667892</PMID>
  </reference>
  <reference>
    <citation>Turcott RG, Witteles RM, Wang PJ, Vagelos RH, Fowler MB, Ashley EA. Measurement precision in the optimization of cardiac resynchronization therapy. Circ Heart Fail. 2010 May;3(3):395-404. doi: 10.1161/CIRCHEARTFAILURE.109.900076. Epub 2010 Feb 22.</citation>
    <PMID>20176716</PMID>
  </reference>
  <reference>
    <citation>Jia P, Ramanathan C, Ghanem RN, Ryu K, Varma N, Rudy Y. Electrocardiographic imaging of cardiac resynchronization therapy in heart failure: observation of variable electrophysiologic responses. Heart Rhythm. 2006 Mar;3(3):296-310.</citation>
    <PMID>16500302</PMID>
  </reference>
  <reference>
    <citation>Shetty AK, Duckett SG, Ma YL, Kapetanakis S, Ginks M, Bostock J, Carr-White G, Rhode K, Razavi R, Rinaldi CA. The acute hemodynamic response to LV pacing within individual branches of the coronary sinus using a quadripolar lead. Pacing Clin Electrophysiol. 2012 Feb;35(2):196-203. doi: 10.1111/j.1540-8159.2011.03268.x. Epub 2011 Nov 29.</citation>
    <PMID>22126664</PMID>
  </reference>
  <reference>
    <citation>Tysler M, Kneppo P, Turzová M, Svehlíková J, Karas S, Hebláková E, Hána K, Filipová S. Noninvasive assessment of local myocardium repolarization changes using high resolution surface ECG mapping. Physiol Res. 2007;56 Suppl 1:S133-41. Epub 2007 May 31.</citation>
    <PMID>17552884</PMID>
  </reference>
  <reference>
    <citation>van Deursen C, van Geldorp IE, Rademakers LM, van Hunnik A, Kuiper M, Klersy C, Auricchio A, Prinzen FW. Left ventricular endocardial pacing improves resynchronization therapy in canine left bundle-branch hearts. Circ Arrhythm Electrophysiol. 2009 Oct;2(5):580-7. doi: 10.1161/CIRCEP.108.846022. Epub 2009 Aug 10.</citation>
    <PMID>19843927</PMID>
  </reference>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 1, 2013</study_first_submitted>
  <study_first_submitted_qc>November 21, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 27, 2013</study_first_posted>
  <last_update_submitted>March 30, 2016</last_update_submitted>
  <last_update_submitted_qc>March 30, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 31, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oslo University Hospital</investigator_affiliation>
    <investigator_full_name>Erik Kongsgaard</investigator_full_name>
    <investigator_title>MD, Ph.d</investigator_title>
  </responsible_party>
  <keyword>Heart failure</keyword>
  <keyword>Bundle branch block</keyword>
  <keyword>CRT response</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

